CLASSIC HODGKIN LYMPHOMA
Clinical trials for CLASSIC HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for frail hodgkin patients: immunotherapy-chemo combo shows promise
Disease control Recruiting nowThis study tests a combination of the immunotherapy drug pembrolizumab and three chemotherapy drugs (gemcitabine, brentuximab vedotin, and dacarbazine) in 23 frail patients newly diagnosed with classical Hodgkin lymphoma who cannot tolerate standard treatment. The goal is to see …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
Blood test may let some hodgkin patients skip extra chemo
Disease control Recruiting nowThis study tests whether a blood test that measures tumor DNA can help doctors safely reduce the amount of chemotherapy for people with advanced Hodgkin lymphoma. About 125 participants will receive either fewer or standard chemo cycles based on their test results. The goal is to…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Can a blood test predict heart trouble in childhood cancer survivors?
Knowledge-focused Recruiting nowThis study looks at how certain blood cell changes (called clonal hematopoiesis) after Hodgkin lymphoma treatment might be linked to heart problems later in life. Researchers will check blood samples from 190 survivors who had chemotherapy as children or teens. The goal is to fin…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC